【ChiCTR2300072788】Effects of a multicomponent intervention on functional ability in community-dwelling older people: a randomized controlled trial
ChiCTR2300072788
尚未开始
/
/
/
2023-06-25
/
/
Functional ability
Effects of a multicomponent intervention on functional ability in community-dwelling older people: a randomized controlled trial
Effects of a multicomponent intervention on functional ability in community-dwelling older people: a randomized controlled trial
To conduct a 12-week group-based multicomponent intervention for 300 persons aged 60 years or older to improve functional ability, and to promote healthy ageing.
随机平行对照
其它
To obtain an adequate sample size, community centres under the eHealth project with the largest number of participants who have orare at risk of sarcopenia will be selected. Fifteen centres will be randomly selected and allocated to either group 1(receiving the multicomponent intervention without goal-setting), group 2 (receiving the multicomponent intervention with goal-setting), or group 3 (receiving the HLE program). We choose cluster RCT because randomization at the cluster (centre) level will reduce the likelihood of experimental contamination. Group 1 - receiving the multicomponent intervention without goal-setting. Group 2 - receiving the multicomponent intervention with goal-setting. Group 3 - receiving the HLE program.
Not stated
The Hong Kong Jockey Club Charities Trust
/
100
/
2023-07-01
2024-06-30
/
1. Community-dwelling older men or women aged 60 years and older; 2. Understand Cantonese; 3. With limited mobility without mobility disability (Short Physical Performance Battery score = 3-9); 4. Assessed with possible sarcopenia (low muscle strength (handgrip strength M: < 28 kg, F: < 18 kg) or low physical performance (5-chair rise test >= 12 s)); 5. Diagonised with sarcopenia (low appendicular skeletal muscle mass (bioelectrical impedance analysis M: < 7.0kg/m2, F: < 5.7kg/m2) and low muscle strength (handgrip strength M: < 28 kg, F: < 18 kg) and/or low physical performance (5-chair rise test >= 12 s)); 6. With history of falls in the past year; 7. With physical pre-frailty/frailty (FRAIL score >= 1); 8. With cognitive impairment (Montreal Cognitive Assessment 5-Minute Protocol Hong Kong Version score <= age and education corrected percentile cutoff, without doctor diagnosed dementia); 9. With impaired vitality (Mini Nutritional Assessment Short-Form score <= 11/low muscle strength (handgrip strength M: < 28 kg, F: < 18 kg).;
请登录查看1. Unable to get up from a chair (with or without using the armrests) and stand for 20 seconds; 2. Receive treatment for medical conditions that preclude physical activity; 3. Diagnosis of dementia, dementia suspected by a clinician, or terminal illness; 4. Interviewer-adjudicated severe visual or hearing impairment; 5. Participation in a structured physical activity program, nutritional activities or board game activities; 6. Contraindications to safely engage in trial activities as judged by health professionals (e.g., doctors, nurses, physiotherapists etc.).;
请登录查看The Hong Kong Jockey Club Charities Trust
/
The Hong Kong Jockey Club Charities Trust的其他临床试验
- Effects of a multicomponent intervention on functional ability in community-dwelling older people: a randomized controlled trial
- Effectiveness of post hospital discharge support program to improve the well-being of people with dementia and family caregivers
- Unpacking the concept of physical literacy to support children's physical literacy journey: a parent-focused intervention
- Effectiveness of a dementia friendly program and bluetooth tracking technology to enhance public knowledge and attitude on dementia and reduce caregiver anxiety on getting lost
CUHK Jockey Club Institute of Ageing的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验(FIH)成功开展,国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药:超长效靶向TSLP抗体哮喘二期临床取得阳性结果,三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构:国家市场监督管理总局 2026-09-18
-
颁布机构:国家市场监督管理总局 2026-09-17
-
颁布机构:国家市场监督管理总局 2026-08-10
